This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Compliance & Legal, Biotech & Pharma
EU Pharmaceutical Law

EU Pharmaceutical Law Forum 2020: Post-event Report

Posted by on 16 December 2020
Share this article

Throughout the week of 16-20 November 2020, the EU Pharmaceutical Law Forum took place as a virtual conference for the first time.

Professionals from across the pharmaceutical industry and around the world gathered online to learn the latest updates around drug pricing, healthcare data privacy, competition law enforcement, use of off-label products, medical device regulations and much more.

Delivered live and on-demand, sessions were presented by legal and regulatory experts active in the healthcare and pharmaceutical sectors.

Whether or not you joined us for the event, we invite to join us as we look back at the highlights. In this report, we explore the most popular presentations and discussion forums including:

  • EU Commission Update on the Regulatory Landscape
  • On-going Tensions Surrounding GDPR and Data Sharing for the Pharmaceutical Industry
  • New Market Trends in the Pharmaceutical Industry: Impact on Licensing and M&A
  • Affordability of Medicines, Price Transparency and Market Access
  • EU MDR Regulations for eHealth, Mobile Apps and Artificial Intelligence
  • Legal Considerations Regarding the Use of Unapproved Products
  • Pharmaceutical Marketing, Advertising and Promotional Activity

Click the image at the below or here to explore the report.

Share this article